United States: Federal Circuit Vacates Infringement Of Braintree SUPREP Patent

In a divided opinion issued in Braintree Labs., Inc. v. Novel Labs., Inc., the Federal Circuit reversed the district court on one of two challenged claim construction issues and vacated the district court's finding of infringement to remand for further factual findings. When no judge agrees with the basis of the decision and neither party is satisfied with the outcome, what can we learn from this case?

The Patent at Issue

The patent at issue was Braintree's U.S. 6,946,149, which is listed in the Orange Book for its SUPREP® Bowel Prep Kit for preparing patients for colonoscopies. Reexamined claim 15 was treated as representative:

A composition for inducing purgation of the colon of a patient, the composition comprising from about 100 mL to about 500 mL of an aqueous hypertonic solution comprising an effective amount of Na2SO4, an effective amount of MgSO4, and an effective amount of K2SO4, wherein the composition does not produce any clinically significant electrolyte shifts and does not include phosphate.

According to the Federal Circuit decision, "Braintree sells SUPREP® in a kit containing two six-ounce bottles of concentrated solution, along with a dilution cup." To use the product, "[a] patient must dilute each of the two six-ounce bottles with ten ounces of water to form two sixteen-ounce solutions," each of which has a volume of 473 mL. Thus, Braintree's theory of infringement (and basis for listing the patent in the Orange Book for SUPREP®) is that one bottle of the two-bottle kit falls within the scope of the claims. The Federal Circuit decision refers to this as the "one bottle" theory of infringement.

The ANDA Litigation

Novel filed an ANDA seeking approval to market a generic version of SUPREP®, and making a paragraph IV certification against the '149 patent. In the ensuing ANDA litigation, the district court construed the claims, granted summary judgment of infringement, and upheld the validity of the patent after a bench trial.

The claim construction issues challenged on appeal related to the meaning of "purgation" and the meaning of "clinically significant electrolyte shifts." While not treated as an independent claim construction issue, the impact of the term "a patient" in the preamble also was important to the infringement issue.

The Federal Circuit Decision

The Federal Circuit decision was authored by Judge Prost. Judge Dyk wrote an opinion concurring-in-part, dissenting-in-part, and concurring in the result, while Judge Moore wrote a dissenting opinion. The judges appear to agree on the claim construction issues, but disagree on infringement and/or the "patient" issue.

"Purgation"

As noted by the Federal Circuit, "[t]he district court construed 'purgation' to mean 'an evacuation of a copious amount of stool from the bowels after oral administration of the solution.'" Novel argued that "purgation" should mean the type of complete "cleansing" required to permit visualization of the colon for a colonoscopy. The Federal Circuit disagreed, focusing on the plain language of the claims and interpreting "inducing purgation" as meaning "inducing diarrhea."

"clinically significant electrolyte shifts"

As noted by the Federal Circuit, the district court construed "'clinically significant electrolyte shifts'" to be 'alterations in blood chemistry that are both outside the normal upper or lower limits of their range and accompanied by or manifested as other untoward effects.'" The Federal Circuit reversed that claim construction, because the specification expressly defined the term as meaning "alterations in blood chemistry that are outside the normal upper or lower limits of their range or other untoward effects."

Infringement

The Federal Circuit decision vacates the district court's summary judgment of infringement. Judge Dyk concurred in that result, but believes that Novel established non-infringement as a matter of law because he disagrees with the "one bottle" theory of infringement. In contrast, Judge Moore dissents because she disagrees with Judge Prost's treatment of the "a patient" language.

The district court considered infringement from two perspectives:

  • does one bottle of SUPREP® induce purgation
  • does one bottle of SUPREP® avoid producing clinically significant electrolyte shifts

Judge Prost affirmed the district court's decision that one bottle of SUPREP® induces purgation, even though two bottles are required to prepare a patient for a colonoscopy. Judge Dyk disagrees with the "one bottle" theory of infringement because it is inconsistent with the product at issue in the ANDA. That is, because Novel's ANDA sought approval of a two-bottle product wherein the patient is administered a total volume of 946 mL, it could not infringe a claim reciting "a composition with a volume or 100-500 mL for inducing purgation and a method of using the same."

Judge Prost vacated the district court's summary judgment of infringement because there was a genuine issue of material fact as to whether SUPREP® avoids producing clinically significant electrolyte shifts in a patient population. While the district court interpreted the "clinically significant electrolyte shifts" clause in conjunction with the "a patient" referenced in the preamble as requiring that "at least one patient" not experience those effects, Judge Prost interpreted the claim as requiring that "a patient population" not experience those effects. Judge Moore disagrees with the collective view of the side effects clause, and finds that the specification indicates that "clinical significance is measured in an individual patient." Thus, she would have found the product to infringe even if only one patient out of 100 does not experience clinically significant electrolyte shift.

Non-Infringement in the ANDA Context

In the ANDA context, non-infringement is found if making, using, or selling the proposed generic product for use in accordance with the approved labeling does not infringe the Orange Book listed patent(s). In many cases, generic companies may be able to design around the patents in such a way that the generic product is somewhat different from the approved brand name product. In this case, however, Novel's proposed product appears to be identical to SUPREP®. Thus, a finding that Novel's ANDA does not infringe the patent would indicate that the Orange Book listed patent does not, in fact, cover the approved product and so should not have been listed in the Orange Book.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

    Disclaimer

    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

    Registration

    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

    Cookies

    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

    Links

    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

    Mail-A-Friend

    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

    Emails

    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

    Security

    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions